Interestingly, the use of this immune-compromised NSG tumor model reveals a tumor-suppressive effect of COX-2 inhibitors, which appears to be mediated through tumor-stromal interactions, independent of the inflammatory effects triggered by PGE2 (111). Here, PTGS2 is linked to neoplasm.